Patients whose BP during baseline treatment period is: SBP\>=200mmHg or DBP\>=120mmHg.
Patients with secondary hypertension or hypertensive emergency.
Patients with cardiovascular or cerebrovascular ischemic event (stroke, transient ischemic attack (TIA), myocardial infarction or unstable angina), or with history of these within 6 months prior to the study.
Patients with intracranial or subarachnoid hemorrhage, or with history of these within 6 months prior to the study.
Patients with server hematopoietic dysfunction (acute/chronic leukemia, myeloma, malignant lymphoma, myelodysplastic syndrome, aplastic anemia), or with history of these.